This result is consistent with multiple studies reporting that BTG2 plays an anti-proliferative role in breast cancer [52, 53], pancreatic cancer [54], and vertebral patterning by modulating bone morphogenesis [55], homeotic transformation of the axial skeleton [56, 57], and stress response [18]. This evidence concerns the gene BTG2 and pancreatic neoplasm.